Biology of the immunomodulatory molecule HLA-G in human liver diseases
- PMID: 25772038
- DOI: 10.1016/j.jhep.2015.03.007
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Abstract
The non-classical human leukocyte antigen-G (HLA-G), plays an important role in inducing tolerance, through its immunosuppressive effects on all types of immune cells. Immune tolerance is a key issue in the liver, both in liver homeostasis and in the response to liver injury or cancer. It would therefore appear likely that HLA-G plays an important role in liver diseases. Indeed, this molecule was recently shown to be produced by mast cells in the livers of patients infected with hepatitis C virus (HCV). Furthermore, the number of HLA-G-positive mast cells was significantly associated with fibrosis progression. The generation of immune tolerance is a role common to both HLA-G, as a molecule, and the liver, as an organ. This review provides a summary of the evidence implicating HLA-G in liver diseases. In the normal liver, HLA-G transcripts can be detected, but there is no HLA-G protein. However, HLA-G protein is detectable in the liver tissues and/or plasma of patients suffering from hepatocellular carcinoma, hepatitis B or C, or visceral leishmaniasis and in liver transplant recipients. The cells responsible for producing HLA-G differ between diseases. HLA-G expression is probably induced by microenvironmental factors, such as cytokines. The expression of HLA-G receptors, such as ILT2, ILT4, and KIRD2L4, on liver cells has yet to be investigated, but these receptors have been detected on all types of immune cells, and such cells are present in liver. The tolerogenic properties of HLA-G explain its deleterious effects in cancers and its beneficial effects in transplantation. Given the key role of HLA-G in immune tolerance, new therapeutic agents targeting HLA-G could be tested for the treatment of these diseases in the future.
Keywords: HLA-G; Hepatocellular carcinoma; Liver failure; Transplantation; Viral hepatitis.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.J Hepatol. 2014 Feb;60(2):245-52. doi: 10.1016/j.jhep.2013.09.006. Epub 2013 Sep 12. J Hepatol. 2014. PMID: 24036009
-
Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma.Hum Immunol. 2014 Dec;75(12):1225-31. doi: 10.1016/j.humimm.2014.09.019. Epub 2014 Oct 12. Hum Immunol. 2014. PMID: 25318079 Review.
-
Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection.Hum Immunol. 2012 Mar;73(3):258-62. doi: 10.1016/j.humimm.2011.12.004. Epub 2011 Dec 8. Hum Immunol. 2012. PMID: 22178697
-
HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease.Front Immunol. 2022 Jan 27;13:796054. doi: 10.3389/fimmu.2022.796054. eCollection 2022. Front Immunol. 2022. PMID: 35154112 Free PMC article. Review.
-
The immunosuppressive molecule HLA-G and its clinical implications.Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):63-84. doi: 10.3109/10408363.2012.677947. Epub 2012 Apr 26. Crit Rev Clin Lab Sci. 2012. PMID: 22537084 Review.
Cited by
-
Exploring the role of mast cells in the progression of liver disease.Front Physiol. 2022 Sep 13;13:964887. doi: 10.3389/fphys.2022.964887. eCollection 2022. Front Physiol. 2022. PMID: 36176778 Free PMC article. Review.
-
Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37.Med Sci Monit. 2016 Apr 26;22:1398-402. doi: 10.12659/msm.895971. Med Sci Monit. 2016. PMID: 27112970 Free PMC article.
-
Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.Clin Transl Immunology. 2020 May 10;9(5):e1128. doi: 10.1002/cti2.1128. eCollection 2020 May. Clin Transl Immunology. 2020. PMID: 32399213 Free PMC article.
-
Role of HLA-G in Viral Infections.Front Immunol. 2022 Feb 14;13:826074. doi: 10.3389/fimmu.2022.826074. eCollection 2022. Front Immunol. 2022. PMID: 35237271 Free PMC article. Review.
-
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions.Front Immunol. 2020 Nov 19;11:565759. doi: 10.3389/fimmu.2020.565759. eCollection 2020. Front Immunol. 2020. PMID: 33329527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials